Accuray's (ARAY) CyberKnife Improves Prostate Cancer Treatment [Yahoo! Finance]
Accuray Incorporated (ARAY)
Last accuray incorporated earnings: 4/28 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.accuray.com/investor-overview
Company Research
Source: Yahoo! Finance
the CyberKnife System in the treatment of high-risk and recurrent prostate cancer. The studies build on years of published clinical follow-up with many patients with prostate cancer at different stages of the disease and with individuals who had radiation therapy earlier, demonstrating the adaptability and usefulness of the approach for healthcare teams. Price Performance For the past six months, ARAY's shares have plunged 13.2% against the industry's rise of 16.7%. The S&P 500 increased 20.5% in the same time frame. Image Source: Zacks Investment Research More on the News The CyberKnife System enables treatment of prostate cancer with stereotactic body radiation therapy (SBRT), a type of radiation therapy that delivers highly concentrated, precisely timed radiation doses over a shorter period than with conventional treatments. Because of the system's accuracy, physicians can safely use SBRT to treat the prostate gland, which is located close to the delicate bladder and re
Show less
Read more
Impact Snapshot
Event Time:
ARAY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARAY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARAY alerts
High impacting Accuray Incorporated news events
Weekly update
A roundup of the hottest topics
ARAY
News
- Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024 [Yahoo! Finance]Yahoo! Finance
- Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024PR Newswire
- Continuous Testing Market size worth $ 7.38 Billion, Globally, by 2031 at 15.55% CAGR – Report By Verified Market Research® [Yahoo! Finance]Yahoo! Finance
- Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland [Yahoo! Finance]Yahoo! Finance
- Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, SwitzerlandPR Newswire
ARAY
Earnings
- 1/31/24 - Miss
ARAY
Sec Filings
- 3/5/24 - Form 4
- 2/13/24 - Form SC
- 2/13/24 - Form SC
- ARAY's page on the SEC website